Related Experiment Video
Updated: Sep 16, 2025

07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
920
ASO Author Reflections: The Landmark Series-Neoadjuvant Therapy for Resectable Pancreatic Cancer
Esther N Dekker1,2, Ching-Wei D Tzeng3
1Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Annals of Surgical Oncology
|July 10, 2025
Abstract
No abstract available in PubMed .

